NTLAIntellia Therapeutics, Inc.

$13.19

Is it safe?

Can NTLA take a bad year?

The deepest fall in NTLA's price history on file is −96%; it is −53% below its high today.

2.52

Altman Z-score · distress below 1.8 · safe above 3 · grey zone: neither safe nor distressed on this model

Cash runway
1.0 years

Cash runway · burning $91M a quarter at the current rate

Annualised volatility
90%

Annualised volatility · three times the market's own swing

Worst drawdown on file
−96%

Worst drawdown on file · −53% today

Details
Cash and short-term investments
$376M
EBITDA, trailing twelve months
−$411M
Operating profit, trailing twelve months
−$421M
Annualised volatilitytwo years of daily moves
90%
Worst drawdown on file
−96%
Below its 52-week high
−53%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.